NCT04692987

Brief Summary

Colorectal cancer (CRC) is the second most common cancer in Malaysia. Diagnosing CRC at early stage is crucial to reduce their mortality risk. To achieve this aim, CRC screening promotion intervention is deemed necessary.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P50-P75 for not_applicable colorectal-cancer

Timeline
Completed

Started Mar 2021

Shorter than P25 for not_applicable colorectal-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 22, 2020

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 5, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

January 5, 2021

Status Verified

December 1, 2020

Enrollment Period

6 months

First QC Date

December 22, 2020

Last Update Submit

December 30, 2020

Conditions

Keywords

ScreeningPrimary careVideo

Outcome Measures

Primary Outcomes (1)

  • Number of participants with colorectal cancer screening completion

    Number of participants with completion of fecal occult blood test or colonoscopy procedures by participants

    3 months

Secondary Outcomes (3)

  • Number of participants with colonoscopy completion among those with positive fecal occult blood test

    3 months

  • Period time from intervention to fecal occult blood test uptake

    3 months

  • Barriers towards the colorectal cancer screening uptake

    3 months

Study Arms (2)

Intervention

EXPERIMENTAL

Participants will receive decision-aid video

Other: Decision-aid video

Usual care

NO INTERVENTION

Participants will receive usual care

Interventions

Decision-aid video will be developed to disseminate knowledge and to raise awareness on colorectal cancer screening

Intervention

Eligibility Criteria

Age50 Years - 74 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Malaysian aged 50 - 74 years old
  • No previous history or family history of CRC
  • Asymptomatic of CRC
  • Never participated in CRC screening

You may not qualify if:

  • Acute patients
  • Patients on aspirin, warfarin or any blood-thinning agent
  • Illiterate or having a significant vision or hearing impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The National University of Malaysia

Cheras, Kuala Lumpur, 56000, Malaysia

Location

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Azmawati Mohammed Nawi

    The National University of Malaysia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Azmawati Mohammed Nawi, Medical

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Investigators will designate participants to which arm using random sampling. Participants and care providers are masked to which arm they receive.
Purpose
SCREENING
Intervention Model
PARALLEL
Model Details: Parallel randomized controlled trial will be conducted in 3 months duration, with intention-to-treat.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Public Health Specialist & Medical Lecturer

Study Record Dates

First Submitted

December 22, 2020

First Posted

January 5, 2021

Study Start

March 1, 2021

Primary Completion

September 1, 2021

Study Completion

March 1, 2022

Last Updated

January 5, 2021

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Only three principal investigators will have access to participants' data

Locations